Vitamin c, gastritis, and gastric disease: A historical review and update

Digestive Diseases and Sciences

Volumn 57, Issue 10, 2012, Pages 2504-2515

  Aditi, Anupam ^a   Graham, David Y ^b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Ascorbic acid; Dehydroascorbic acid; Gastric cancer; Gastritis; Gastrointestinal bleeding; Helicobacter pylori; Intestinal metaplasia; Peptic ulcer; Pernicious anemia; Vitamin C

Indexed keywords

AMOXICILLIN; ASCORBIC ACID; BISMUTH CITRATE; BISMUTH SALICYLATE; CLARITHROMYCIN; DEHYDROASCORBIC ACID; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE;

ACHLORHYDRIA; ASCORBIC ACID DEFICIENCY; DRUG EFFICACY; DUODENUM ULCER; DYSPEPSIA; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HUMAN; IRON DEFICIENCY ANEMIA; LOADING DRUG DOSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PERNICIOUS ANEMIA; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; STOMACH ULCER; URINARY EXCRETION;

ASCORBIC ACID; ASCORBIC ACID DEFICIENCY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH DISEASES;

EID: 84867848490     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2203-7     Document Type: Review

References (86)

1. Carpenter KJ. The History of Scurvy & Vitamin C. New York: Cambridge University Press; 1986.
2. Carpenter KJ, editor. Pellagra. Stroudsburg, PA: Hutchinson Ross Publishing Company; 1981.
3. Carpenter KJ. Beriberi White Rice Vitamin B. A Disease a Cause A Cure. Berkeley University Of California Press; 2000
4. Wilson JX. Regulation of vitamin C transport. Annu Rev Nutr. 2005;25:105-125.
5. Tsukaguchi H, Tokui T, Mackenzie B, et al. A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature. 1999;399:70-75.
6. Waring AJ, Schorah CJ. Transport of ascorbic acid in gastric epithelial cells in vitro. Clin Chim Acta. 1998;275:137-149.
7. Boyer JC, Campbell CE, Sigurdson WJ, et al. Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells. Biochem Biophys Res Commun. 2005;334:150-156.
8. Wilson JX. The physiological role of dehydroascorbic acid. FEBS Lett. 2002;527:5-9.
9. Wrieden WL, Hannah MK, Bolton-Smith C, et al. Plasma vitamin C and food choice in the third Glasgow MONICA population survey. J Epidemiol Community Health. 2000;54:355-360.
10. Ingalls TH, Warren HA. Asymptomatic scurvy: its relation to wound healing and its incidence in patients with peptic ulcer. N Engl J Med. 1937;217:443-446.
11. Szent-Györgyi A. Observations on the function of peroxidase systems and the chemistry of the adrenal cortex: description of a new carbohydrate derivative. Biochem J. 1928;22:1387-1409.
12. Szent-Györgyi A. Identification of vitamin C. Nature. 1933;131: 225-226.
13. Waugh WA, King CG. Isolation and identification of vitamin C. J Biol Chem. 1932;97:325-331.
14. Tillmans J. Das antiskorbutische vitamin. Z Untersuch Lebensm. 1930;60:34.
15. Van Eekelen M, Heinemann M. Critical remarks on the determination of urinary excretion of ascorbic acid. J Clin Invest. 1938;17:293-299.
16. Harris LJ, Abbassy MA, Yudkin J. Vitamin in human nutrition. Vitamin C reserves of subjects of the voluntary hospital class. Lancet. 1936;1:1488-1490.
17. Archer HE, Graham G. The subscurvy state in relation to gastric and duodenal ulcer. Lancet 1936;ii:383-385.
18. Ingalls TH. Studies on the urinary excretion and blood concentration of ascorbic acid in infantile scurvy. J Pediatr. 1937;10:577-591.
19. Field H Jr, Robinson WD, Melnick D. Vitamins in peptic ulcer. Ann Intern Med. 1940;14:378-392.
20. Riggs H, Reinhold J, Boyles R. Qualitative circulatory deficiencies observed in peptic ulcer. Am J Dig Dis. 1941;8:383-385.
21. Portnoy B, Wilkinson JF. Vitamin C deficiency in peptic ulceration. Br Med J. 1938;1:554-560.
22. Crescenzo VM, Cayer D. Plasma vitamin C levels in patients with peptic ulcer. Response to oral load test of ascorbic acid. Gastroenterology. 1947;8:754-761.
23. Freeman JT, Hafkesbring R. Comparative studies of ascorbic acid levels in gastric secretion and blood. III. Gastrointestinal diseases. Gastroenterology. 1957;32:878-886.
24. Ludden JB, Flexner J, Wright IS. Studies on ascorbic acid deficiency in gastric diseases: incidence, diagnosis, and treatment. Am J Dig Dis. 1941;8:249-252.
25. Sippy B. Gastric and duodenal ulcer; medical cure by an efficient removal of gastric juice corrosion. JAMA. 1915;64:1625-1630.
26. Ebbesen I, Rasmussen M. Some investigations on the ascorbic acid content in serum from patients suffering from peptic ulcer. Acta Med Scand. 1944;117:507.
27. Davidson PB. The development of deficiency disease during therapeutic diets. JAMA. 1928;90:1014-1015.
28. Platt R. Scurvy as the result of dietetic treatment. Lancet 1936;ii:366-367.
29. Henry EB, Carswell A, Wirz A, et al. Proton pump inhibitors reduce the bioavailability of dietary vitamin C. Aliment Pharmacol Ther. 2005;22:539-545.
30. Heinemann M. Requirements for vitamin C in man. J Clin Invest. 1938;17:671-676.
31. Warren HA, Pijoan M, Emery ES Jr. Ascorbic acid requirements in patients with peptic ulcer. NEJM. 1939;220:1061-1063.
32. Breidenback AW, Ray FE. Gastric ascorbic acid in the gastritic guinea pig. Science. 1953;118:557.
33. Kendall AI, Chinn H. Decomposition of ascorbic acid by certain bacteria. J Infect Dis. 1938;62:330-336.
34. Alt HA, Chinn H, Farmer CJ. The blood plasma ascorbic acid in patients with achlorhydria. Am J Med Sci. 1939;197:222-232.
35. Mowat C, McColl KE. Alterations in intragastric nitrite and vitamin C levels during acid inhibitory therapy. Best Pract ResClin Gastroenterol. 2001;15:523-537.
36. Marcuard SP, Albernaz L, Khazanie PG. Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12). Ann Intern Med. 1994;120:211-215.
37. Koop H, Bachem MG. Serum iron, ferritin, and vitamin B12 during prolonged omeprazole therapy. J Clin Gastroenterol. 1992;14:288-292.
38. Golubov J, Flanagan P, Adams P. Inhibition of iron absorption by omeprazole in rat model. Dig Dis Sci 1991;36:405-408.
39. Morris GE. Avitaminosis C in 1953: a clinical study. Ann Intern Med. 1958;5:393-394.
40. Weiss S, Weiss J, Weiss B. Gastrointesinal haemorrhage: therapeutic evaluation of bioflavonoids. Report on 55 cases. Am J Gastroenterol 1955;24:523-532.
41. McAlindon ME, Muller AF, Filipowicz B, et al. Effect of allopurinol, sulphasalazine, and vitamin C on aspirin-induced gastroduodenal injury in human volunteers. Gut. 1996;38:518-524.
42. Rokkas T, Papatheodorou G, Karameris A, Giannikos N. Helicobacter pylori infection and gastric juice vitamin C levels. Impact of eradication. Dig Dis Sci. 1995;40:615-621.
43. Woodward M, Tunstall-Pedoe H, McColl K. Helicobacter pylori infection reduces systemic availability of dietary vitamin C. Eur JGastroenterol Hepatol 2001;13:233-237.
44. Capurso G, Ricci R, Panzuto F, Baccini F, et al. Intragastric ascorbic but not uric acid is depleted in relation with the increased pH in patients with atrophic body gastritis and H. Pylori gastritis. Helicobacter. 2003;8:300-306.
45. Simon JA, Hudes ES, Perez-Perez GI. Relation of serum ascorbic acid to Helicobacter pylori serology in US adults: the Third National Health and Nutrition Examination Survey. J Am Coll Nutr. 2003;22:283-289.
46. Banerjee S, Hawksby C, Miller S, et al. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut. 1994;35:317-322.
47. Sobala GM, Crabtree JE, Dixon MF, et al. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut. 1991;32:1415-1418.
48. O'Connor HJ, Schorah CJ, Habibzedah N, et al. Vitamin C in the human stomach: relation to gastric pH, gastroduodenal disease, and possible sources. Gut. 1989;30:436-442.
49. Waring AJ, Drake IM, Schorah CJ, et al. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: effects of gastritis and oral supplementation. Gut. 1996;38:171-176.
50. Rood JC, Ruiz B, Fontham ET, et al. Helicobacter pyloriassociated gastritis and the ascorbic acid concentration in gastric juice. Nutr Cancer. 1994;22:65-72.
51. Rokkas T, Liatsos C, Petridou E, et al. Relationship of Helicobacter pylori CagA(+) status to gastric juice vitamin C levels. Eur J Clin Invest. 1999;29:56-62.
52. Mowat C, Carswell A, Wirz A, et al. Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. Gastroenterology. 1999;116:813-822.
53. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol. 1995;90:1401-1406.
54. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - first American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52: 6735-6740.
55. Graham DY, Opekun AR, Yamaoka Y, et al. Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther. 2003;17:193-200.
56. Odum L, Andersen LP. Investigation of Helicobacter pylori ascorbic acid oxidating activity. FEMS Immunol Med Microbiol. 1995;10:289-294.
57. Goodman KJ, Correa P, Tengana Aux HJ, et al. Nutritional factors and Helicobacter pylori infection in Colombian children. J Pediatr Gastroenterol Nutr. 1997;25:507-515.
58. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986;8:1-27.
59. Graham DY, Asaka M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol. 2010;45:1-8.
60. Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology. 1997;113:1983-1991.
61. Sugimura T, Sugano H, Terada M, et al. First international workshop of the Princess Takamatsu cancer research fund: intestinalmetaplasia and gastric cancer. Mol Carcinog. 1994;11:1-7.
62. Correa P, Cuello C, Fajardo LF, et al. Diet and gastric cancer: nutrition survey in a high-risk area. J Natl Cancer Inst. 1983;70: 673-678.
63. Comfort MW. Gastric acidity before and after development of gastric cancer: its etiologic, diagnostic and prognostic significance. Ann Intern Med. 1951;36:1331-1348.
64. Sobala GM, Schorah CJ, Sanderson M, et al. Ascorbic acid in the human stomach. Gastroenterology. 1989;97:357-363.
65. Fontham E, Zavala D, Correa P, et al. Diet and chronic atrophic gastritis: a case-control study. J Natl Cancer Inst. 1986;76: 621-627.
66. Iacopini F, Consolazio A, Bosco D, et al. Oxidative damage of the gastric mucosa in Helicobacter pylori-positive chronic atrophic and nonatrophic gastritis, before and after eradication. Helicobacter. 2003;8:503-512.
67. Drake IM, Davies MJ, Mapstone NP, et al. Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis. 1996;17:559-562.
68. Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst.2000;92:1881-1888.
69. Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett. 1995;93:17-48.
70. Mirvish SS. Inhibition by vitamins C and E of in vivo nitrosation and vitamin C occurrence in the stomach. Eur J Cancer Prev. 1996;5:131-136.
71. Mirvish SS, Wallcave L, Eagen M, et al. Ascorbate-nitrite reaction: possible means of blocking the formation of carcinogenic N-nitroso compounds. Science. 1972;177:65-68.
72. Iijima K, Fyfe V, McColl KE. Studies of nitric oxide generation from salivary nitrite in human gastric juice. Scand J Gastroenterol. 2003;38:246-252.
73. Mowat C, Williams C, Gillen D, et al. Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology. 2000;119:339-347.
74. Verdu EF, Armstrong D, Fraser R, et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut. 1995;36:539-543.
75. Hemila H, Roberts P, Wikstrom M. Activated polymorphonuclear leucocytes consume vitamin C. FEBS Lett. 1984;178:25-30.
76. Drake IM, Mapstone NP, Schorah CJ, et al. Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: relation to gastric mucosal ascorbic acid concentrations and effect of H. pylori eradication. Gut. 1998;42: 768-771.
77. Wright ME, Andreotti G, Lissowska J, et al. Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric cancer in Poland. Eur J Cancer. 2009;45:1824-1830.
78. Yoshinaga M, Ohtani A, Harada N, et al. Vitamin C inhibits corpus gastritis in Helicobacter pylori-infected patients during acid-suppressive therapy. J Gastroenterol Hepatol. 2001;16:1206-1210.
79. Zhang HM, Wakisaka N, Maeda O, et al. Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori. Cancer. 1997;80:1897-1903.
80. Jarosz M, Dzieniszewski J, Browska-Ufniarz E, et al. Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev. 1998;7:449-454.
81. Zojaji H, Talaie R, Mirsattari D, et al. The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation. Dig Liver Dis. 2009;41:644-647.
82. Sezikli M, Cetinkaya ZA, Sezikli H, et al. Oxidative stress in Helicobacter pylori infection: does supplementation with vitamins C and E increase the eradication rate? Helicobacter. 2009;14:280-285.
83. Chuang CH, Sheu BS, Kao AW, et al. Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication. Hepatogastroenterology. 2007;54: 320-324.
84. Kaboli SA, Zojaji H, Mirsattari D, et al. Effect of addition of vitamin C to clarithromycin-amoxicillin-omeprazol triple regimen on Helicobacter pylori eradication. Acta Gastroenterol Belg.2009;72:222-224.
85. Kamiji MM, Oliveira RB. Effect of vitamin C administration on gastric colonization by Helicobacter pylori. Arq Gastroenterol. 2005;42:167-172.
86. Chuang CH, Sheu BS, Huang AH, et al. Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection. Helicobacter. 2002;7:310-316.